{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:56:31Z","timestamp":1759366591832,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":766,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.4103\/ijmm.ijmm_18_248","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T06:17:20Z","timestamp":1568960240000},"page":"95-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relative Potency of Different Generic Brands of Meropenem, Colistin and Fosfomycin: Implications for Antimicrobial Therapy and Antimicrobial Formulary"],"prefix":"10.1016","volume":"37","author":[{"given":"Parijat","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishwaranjan","family":"Jana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kingshuk","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mammen","family":"Chandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/ijmm.IJMM_18_248_bib1","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.4103\/0976-500X.120972","article-title":"Safety and efficacy of generic drugs with respect to brand formulation","volume":"4","author":"Gallelli","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"10.4103\/ijmm.IJMM_18_248_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jac\/dkn090","article-title":"Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method","volume":"61","author":"Bonev","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.4103\/ijmm.IJMM_18_248_bib3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jiph.2016.10.005","article-title":"Relative potency of different generic brands of piperacillin-tazobactam: Implications for public health","volume":"10","author":"Das","year":"2017","journal-title":"J Infect Public Health"},{"key":"10.4103\/ijmm.IJMM_18_248_bib4","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1128\/AAC.06012-11","article-title":"Therapeutic equivalence requires pharmaceutical, pharmacokinetic, and pharmacodynamic identities: True bioequivalence of a generic product of intravenous metronidazole","volume":"56","author":"Agudelo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_18_248_bib5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/AAC.00350-13","article-title":"Even apparently insignificant chemical deviations among bioequivalent generic antibiotics can lead to therapeutic nonequivalence: The case of meropenem","volume":"58","author":"Agudelo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_18_248_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2125.2009.03399.x","article-title":"Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers","volume":"68","author":"Del Tacca","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.4103\/ijmm.IJMM_18_248_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0976-9668.198351","article-title":"Generic versus branded medicines: An observational study among patients with chronic diseases attending a public hospital outpatient department","volume":"8","author":"Das","year":"2017","journal-title":"J Nat Sci Biol Med"},{"issue":"Suppl 2","key":"10.4103\/ijmm.IJMM_18_248_bib8","first-page":"S104","article-title":"Effectiveness and safety of generic formulation of piperacillin\/tazobactam (Astaz-P) for treatment of infected patients at Siriraj hospital","volume":"96","author":"Charoenpong","year":"2013","journal-title":"J Med Assoc Thai"},{"issue":"Suppl 1","key":"10.4103\/ijmm.IJMM_18_248_bib9","first-page":"S117","article-title":"Therapeutic equivalence of generic imipenem\/cilastatin for therapy of infections at Siriraj hospital","volume":"93","author":"Piyasirisilp","year":"2010","journal-title":"J Med Assoc Thai"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720312421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720312421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:18:25Z","timestamp":1759346305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720312421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0255085720312421"],"URL":"https:\/\/doi.org\/10.4103\/ijmm.ijmm_18_248","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relative Potency of Different Generic Brands of Meropenem, Colistin and Fosfomycin: Implications for Antimicrobial Therapy and Antimicrobial Formulary","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/ijmm.IJMM_18_248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Indian Journal of Medical Microbiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}